Skip to main content
Premium Trial:

Request an Annual Quote

BioGX Gets CE-IVD Mark for Multigene POC COVID-19 Test

NEW YORK – BioGX said on Wednesday that it has obtained CE-IVD marking for a point-of-care, multiplex RT-PCR SARS-CoV-2 assay.

The test targets the N1, RdRp, and M gene regions of the virus and uses the firm's Xfree direct-from-sample chemistries.

It runs on BioGX's Pixl platform, a portable, 4-channel, 16-well real-time PCR platform that offers turnaround times of less than an hour for up to 16 samples.

The Pixl system also features integrated results interpretation and reporting, as well as a touchpad-based interface, BioGX said. Testing requires one drop of sample added directly to the freeze-dried Xfree chemistries.

"Pixl combined with our unique Xfree chemistry offers our customers the ease-of-use and affordability of antigen-based testing with the superior sensitivity and specificity of real-time PCR testing," Shazi Iqbal, CEO of BioGX, said in a statement.

Headquartered in Birmingham, Alabama, and Dallas, with an international subsidiary in Amsterdam, BioGX obtained CE-IVD marking for a combination SARS-CoV-2, influenza A and B, and respiratory syncytial virus test two years ago. It also signed an agreement with Cepheid last month to develop a monkeypox assay.

BioGX said it is also developing a pipeline of Xfree-Pixl tests that will enable simple and affordable POC PCR testing.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.